Tag: NESVS 2024
BEST-CLI: Trial results endure in analysis of patients who presented with...
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research...
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs.
Despite...
NESVS 2024: Simons becomes first woman president of New England Society...
Jessica P. Simons, MD, has become the 2024–25 president of the New England Society for Vascular Surgery (NESVS). She is the first woman to...
VQI analysis of CLTI practice following BEST-CLI finds no pick up...
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical...